Dow Up 0.08% Nasdaq Down 0.30%

CytRx Corporation (CYTR)

-NasdaqCM
2.75 0.03(1.08%) Sep 19, 3:59PM EDT
Prev Close:2.78
Open:2.81
Bid:2.67 x 2600
Ask:3.29 x 500
1y Target Est:11.00
Beta:1.06
Next Earnings Date:N/A
Day's Range:2.67 - 2.83
52wk Range:2.00 - 8.35
Volume:1,381,623
Avg Vol (3m):1,093,990
Market Cap:153.31M
P/E (ttm):N/A
EPS (ttm):-0.95
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTR

Comparison

Symbol% ChgMkt Cap
CYTRDown 1.08%153.31M
LLY71.30B
NVS227.82B
SNY148.77B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,549.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.70
Quarterly EPS Est (Sep-14) :-0.25
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate includes aldoxorubicin that has completed Phase IIb clinical trial as a first-line therapy for soft t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback